1.
Indian J Ophthalmol
;
2008 May-Jun; 56(3): 258-9
Article
in English
| IMSEAR
| ID: sea-71273
Subject(s)
Angiogenesis Inhibitors/administration & dosage , Anterior Chamber/blood supply , Antibodies, Monoclonal/administration & dosage , Blindness/complications , Humans , Injections , Neovascularization, Pathologic/drug therapy , Pain/complications , Time Factors , Vascular Endothelial Growth Factor A/antagonists & inhibitors
2.
Indian J Ophthalmol
;
2007 Nov-Dec; 55(6): 460-2
Article
in English
| IMSEAR
| ID: sea-72221
ABSTRACT
Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months of follow-up.